ANI Pharmaceuticals Inc (NAS:ANIP)
$ 56.15 1.83 (3.37%) Market Cap: 1.18 Bil Enterprise Value: 1.21 Bil PE Ratio: 48.83 PB Ratio: 2.59 GF Score: 86/100

Q1 2020 ANI Pharmaceuticals Inc Earnings Call Transcript

May 07, 2020 / 02:30PM GMT
Release Date Price: $34.06 (-7.85%)
Operator

Good morning, everyone, and welcome to ANI's First Quarter 2020 Earnings Call. At (Operator Instructions)

It is now my pleasure to turn today's program over to Mr. Arthur Przybyl, President and CEO of ANI Pharmaceuticals. Please go ahead, sir.

Arthur Przybyl;President and CEO

Thank you, Tasha. Good morning, everyone. And welcome to ANI's Earnings Conference Call for the First Quarter of 2020. My name is Art Przybyl, I'm the CEO. And joining me today is Stephen Carey, our Financial Officer; and Patrick Walsh, an ANI Board member, who will be stepping in as interim CEO upon my departure.

Before we begin, I want to refer everyone to the forward-looking statements language in this morning's press release and ask each of you to review it carefully as important context for this conference call.

Discussions will also include certain financial measures that were not prepared in accordance with generally accepted accounting principles. Reconciliation of those non-GAAP financial measures can be found in our earnings release dated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot